GlassScriptPhysician profile
Katherine Arnp Newman
NPI 1558803841
$9,932.24
in general payments reported to CMS, 2019-2025
42 companies · $1,947 in 2025
The $1,947 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,458 · 2022: $1,791 · 2023: $2,283 · 2024: $2,454 · 2025: $1,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,598 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,598.31 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,515.12 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $1,118.35 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,111.39 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,037.29 | 2021-2025 | |
| Amgen INC. | $876.41 | 2021-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $603.35 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $526.84 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $518.69 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $424.48 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $303.30 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $231.86 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $165.88 | 2021-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Astellas Pharma US INC | $152.44 | 2023-2024 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $118.06 | 2021-2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $115.49 | 2021-2023 | Xarelto |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.